| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc2b03342511abc88f60c63f2acd96d0 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-737 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-737 |
| filingDate |
2001-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25527f0f6deb15f8c52bf680064f09b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c94e28cfeb2332a2be4561c73c183e32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_158ba31a02cbf44fddf6e58a55ef259d |
| publicationDate |
2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6340774-B1 |
| titleOfInvention |
Non-steroidal estrogen-receptor antagonists |
| abstract |
This invention relates generally to non-steroidal estrogen-receptor (ER) antagonists that are useful as therapeutics in the treatment of advanced stage breast cancer. More particularly, this invention relates to the cloning and heterologous expression of genes encoding ER antagonists. This invention also relates to the use of such expression to overproduce the ER antagonist and analogs thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013130832-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2826475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017081171-A1 |
| priorityDate |
2000-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |